To summarize the last article: GLP-1 medications are reshaping modern medicine because they target the gut-brain-metabolic axis that drives most chronic disease - not just weight loss, but cardiovascular disease, heart failure, kidney disease, neurodegeneration, fatty liver, and systemic inflammation
Frontiers in molecular biosciences, 9, 925700
(5.8) Bullous Pemphigoid: There have been postmarketing reports requiring hospitalization in patients taking DPP-4 inhibitors
Post-Inflammatory Hyperpigmentation (PIH): Dark marks left behind after acne or skin trauma can take months to fade
Together, they promote fat metabolism, improve energy, and support liver function